# Achieve Life Sciences, Inc.: filings

ACHV · Nasdaq · CIK 949858 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/achv.md) · [Financials](/companies/achv/financials.md) · [Filings](/companies/achv/filings.md) · [Insiders](/companies/achv/insiders.md)

## Reports and events: 327 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 314, 8-K 207, SC 13G/A 57, 10-Q 53, CORRESP 39, 3 36, SC 13G 32, UPLOAD 25, 424B5 22, EFFECT 22, 4/A 21, 10-K 18, DEF 14A 18, S-8 18, S-3 13, 425 12, PRE 14A 10, ARS 8, SCHEDULE 13G 8, S-1/A 7, CT ORDER 6, S-1 6, SC 13D/A 6, 5 5, FWP 4, SC 13D 4, SCHEDULE 13G/A 4, 424B4 3, S-4/A 3, 10-K/A 2, 10-Q/A 2, 424B3 2, 8-K/A 2, D 2, DEL AM 2, POS AM 2, PRER14A 2, S-1MEF 2, S-3/A 2, SCHEDULE 13D 2, 144 1, 424B7 1, D/A 1, DEFC14A 1, PREC14A 1, S-4 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 20:49 ET | [8-K](/filings/0001193125-26-410781.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-410781 |
| 2026-08-14 | 20:09 ET | [8-K](/filings/0001193125-26-352229.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-352229 |
| 2026-08-11 | 20:09 ET | [10-Q](/filings/0001193125-26-344624.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344624 |
| 2026-08-11 | 20:04 ET | [8-K](/filings/0001193125-26-344571.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344571 |
| 2026-07-06 | 20:06 ET | [8-K](/filings/0001193125-26-296174.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-296174 |
| 2026-06-08 | 20:06 ET | [DEF 14A](/filings/0000949858-26-000006.md) | Proxy statement, period 2026-06-08 | 0000949858-26-000006 |
| 2026-06-02 | 12:51 ET | [8-K](/filings/0001193125-26-252624.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-252624 |
| 2026-05-12 | 11:21 ET | [10-Q](/filings/0001193125-26-218177.md) | Quarterly report, period 2026-03-31 | 0001193125-26-218177 |
| 2026-05-12 | 11:20 ET | [8-K](/filings/0001193125-26-218175.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-218175 |
| 2026-04-30 | 20:20 ET | [10-K/A](/filings/0001193125-26-197402.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-197402 |
| 2026-04-27 | 21:28 ET | [SCHEDULE 13D](/filings/0000905148-26-001871.md) | Ownership report, active investor | 0000905148-26-001871 |
| 2026-04-24 | 21:03 ET | [SCHEDULE 13D](/filings/0001999371-26-009036.md) | Ownership report, active investor | 0001999371-26-009036 |
| 2026-04-16 | 20:47 ET | [8-K](/filings/0001193125-26-159189.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-159189 |
| 2026-03-24 | 11:10 ET | [10-K](/filings/0001193125-26-120690.md) | Annual report, period 2025-12-31 | 0001193125-26-120690 |
| 2026-03-24 | 11:05 ET | [8-K](/filings/0001193125-26-120687.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-120687 |
| 2025-11-06 | 12:15 ET | [10-Q](/filings/0001193125-25-268074.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268074 |
| 2025-11-06 | 12:10 ET | [8-K](/filings/0001193125-25-268056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268056 |
| 2025-10-07 | 20:51 ET | [8-K](/filings/0001193125-25-233581.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-233581 |
| 2025-09-11 | 21:12 ET | [8-K](/filings/0001193125-25-201418.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-201418 |
| 2025-08-07 | 11:40 ET | [10-Q](/filings/0000950170-25-104571.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104571 |
| 2025-08-07 | 11:36 ET | [8-K](/filings/0000950170-25-104569.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104569 |
| 2025-06-27 | 21:28 ET | [8-K](/filings/0000950170-25-091055.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-091055 |
| 2025-06-06 | 20:53 ET | [8-K](/filings/0000950170-25-083214.md) | 5.07 Shareholder vote results | 0000950170-25-083214 |
| 2025-05-13 | 11:38 ET | [10-Q](/filings/0000950170-25-069806.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069806 |
| 2025-05-13 | 11:34 ET | [8-K](/filings/0000950170-25-069804.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069804 |
| 2025-04-28 | 20:09 ET | [DEF 14A](/filings/0000950170-25-059297.md) | Proxy statement, period 2025-04-28 | 0000950170-25-059297 |
| 2025-03-11 | 11:37 ET | [10-K](/filings/0000950170-25-036831.md) | Annual report, period 2024-12-31 | 0000950170-25-036831 |
| 2025-03-11 | 11:35 ET | [8-K](/filings/0000950170-25-036830.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036830 |
| 2025-02-10 | 21:10 ET | [8-K](/filings/0000950170-25-017068.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-017068 |
| 2025-01-10 | 14:26 ET | [8-K](/filings/0000950170-25-003873.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-003873 |
| 2024-12-09 | 21:23 ET | [8-K](/filings/0000950170-24-134558.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-134558 |
| 2024-11-07 | 21:15 ET | [10-Q](/filings/0000950170-24-123375.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123375 |
| 2024-11-07 | 21:11 ET | [8-K](/filings/0000950170-24-123334.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123334 |
| 2024-09-27 | 20:55 ET | [8-K](/filings/0000950170-24-110066.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-110066 |
| 2024-08-26 | 20:39 ET | [8-K](/filings/0001193125-24-207129.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-24-207129 |
| 2024-08-13 | 20:08 ET | [10-Q](/filings/0000950170-24-096193.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096193 |
| 2024-08-13 | 20:06 ET | [8-K](/filings/0000950170-24-096171.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096171 |
| 2024-07-29 | 12:10 ET | [8-K](/filings/0000950170-24-087118.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-24-087118 |
| 2024-06-27 | 20:10 ET | [8-K](/filings/0000950170-24-078445.md) | 7.01 Regulation FD disclosure | 0000950170-24-078445 |
| 2024-06-06 | 21:07 ET | [8-K](/filings/0000950170-24-069973.md) | 5.07 Shareholder vote results | 0000950170-24-069973 |
| 2024-05-09 | 20:08 ET | [10-Q](/filings/0000950170-24-056929.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056929 |
| 2024-05-09 | 20:05 ET | [8-K](/filings/0000950170-24-056876.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056876 |
| 2024-04-26 | 20:05 ET | [DEF 14A](/filings/0000950170-24-049089.md) | Proxy statement, period 2024-06-05 | 0000950170-24-049089 |
| 2024-03-28 | 20:14 ET | [10-K](/filings/0000950170-24-038049.md) | Annual report, period 2023-12-31 | 0000950170-24-038049 |
| 2024-03-28 | 20:06 ET | [8-K](/filings/0000950170-24-038030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-038030 |
| 2024-02-29 | 21:41 ET | [8-K](/filings/0000950170-24-023189.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-023189 |
| 2023-12-11 | 21:04 ET | [8-K](/filings/0000950170-23-069392.md) | 8.01 Other events | 0000950170-23-069392 |
| 2023-11-09 | 21:08 ET | [10-Q](/filings/0000950170-23-062028.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062028 |
| 2023-11-09 | 21:05 ET | [8-K](/filings/0000950170-23-062005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062005 |
| 2023-08-14 | 20:09 ET | [10-Q](/filings/0000950170-23-042401.md) | Quarterly report, period 2023-06-30 | 0000950170-23-042401 |

Page 1 of 7. [Older](/companies/achv/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.